51°03′55″N 114°08′06″W / 51.0654°N 114.135°W
The Libin Cardiovascular Institute is an entity of Alberta Health Services and the University of Calgary. It connects all cardiovascular research, education and patient care in Southern Alberta, serving a population of about two million. Its more than 1,500 members include physicians, clinicians and other health professionals, researchers and trainees.
The Libin Cardiovascular Institute was made possible through the donation of founding donors Mona and Alvin Libin.
On March 6, 2003, the Alvin and Mona Libin Foundation presented $15 million to Alberta Health Services and the University of Calgary to form the Libin Cardiovascular Institute. It was then the largest one-time donation to the organizations. The institute was formally created on January 27, 2004.
The Foundation renewed their commitment to the Institute in May 2022 with a $7.5 million donation.
Research within the Libin Cardiovascular Institute extends from basic biomedical and clinical research to health outcomes and care delivery research. Notable successes include:
Programs under the jurisdiction of the Libin Cardiovascular Institute include Cardiology and Cardiovascular Surgery, in addition to contributions to other medical programs as well as graduate studies in the sciences.[ citation needed]
The LCI also offers fellowships and/or advanced training in interventional cardiology, electrophysiology, amyloidosis, heart function and cardiac MRI.[ citation needed]
The Libin Cardiovascular Institute is a wide-ranging program of cardiovascular integration which houses a growing list of scientists, clinicians, and researchers from various sites working together to advance the cardiovascular health of Albertans.
The Alberta Heritage Foundation for Medical Research (AHFMR) Prize for Excellence in Cardiovascular Research was established in honour of Mr. Alvin Libin for his many contributions to the AHFMR (now Alberta Innovates).
This $25,000 prize is awarded to an outstanding international researcher whose work has had a major impact on the understanding, prevention, recognition, or treatment of cardiovascular disease.
Past winners include:
51°03′55″N 114°08′06″W / 51.0654°N 114.135°W
The Libin Cardiovascular Institute is an entity of Alberta Health Services and the University of Calgary. It connects all cardiovascular research, education and patient care in Southern Alberta, serving a population of about two million. Its more than 1,500 members include physicians, clinicians and other health professionals, researchers and trainees.
The Libin Cardiovascular Institute was made possible through the donation of founding donors Mona and Alvin Libin.
On March 6, 2003, the Alvin and Mona Libin Foundation presented $15 million to Alberta Health Services and the University of Calgary to form the Libin Cardiovascular Institute. It was then the largest one-time donation to the organizations. The institute was formally created on January 27, 2004.
The Foundation renewed their commitment to the Institute in May 2022 with a $7.5 million donation.
Research within the Libin Cardiovascular Institute extends from basic biomedical and clinical research to health outcomes and care delivery research. Notable successes include:
Programs under the jurisdiction of the Libin Cardiovascular Institute include Cardiology and Cardiovascular Surgery, in addition to contributions to other medical programs as well as graduate studies in the sciences.[ citation needed]
The LCI also offers fellowships and/or advanced training in interventional cardiology, electrophysiology, amyloidosis, heart function and cardiac MRI.[ citation needed]
The Libin Cardiovascular Institute is a wide-ranging program of cardiovascular integration which houses a growing list of scientists, clinicians, and researchers from various sites working together to advance the cardiovascular health of Albertans.
The Alberta Heritage Foundation for Medical Research (AHFMR) Prize for Excellence in Cardiovascular Research was established in honour of Mr. Alvin Libin for his many contributions to the AHFMR (now Alberta Innovates).
This $25,000 prize is awarded to an outstanding international researcher whose work has had a major impact on the understanding, prevention, recognition, or treatment of cardiovascular disease.
Past winners include: